Error: Could not add to watchlist. X

InterMune Inc

+ Watchlist
ITMN:US
Acquired
ITMN:US was acquired by ROG:VX
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-2.57
Market Cap (USD)
-
Shares Outstanding (m)
107.969
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech
Profile
InterMune, Inc. is a biotechnology company. The Company focuses on the research, development and commercialization of therapies in pulmonology and fibrotic diseases. InterMune operates in North America.
ADDRESS
3280 Bayshore Blvd
Brisbane, CA 94005
United States
PHONE
1-415-466-2200
  • John Hodgman
    Exec VP/CFO
  • Giacomo Di Nepi
    Exec VP/Managing Dir:Europe
  • Jonathan A Leff
    Exec VP:Research & Development
  • Paul D Arata
    Exec VP:HR & Administration
Show More